Roscovitine is a potent, selective inhibitor of cyclin-dependent kinases. Roscovitine is being researched for the treatment of non-small cell lung cancer (NSCLC), Cushing’s disease, leukemia, HIV infection, herpes simplex infection, cystic fibrosis and the mechanisms of chronic inflammation disorders.
Cancer Research and Antivirals
|Appearance||white to off-white powder|
Send us your enquiry for Roscovitine. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Roscovitine email us and we will include your contribution on the website.